NEAT1 Knockdown Suppresses the Cisplatin Resistance in Ovarian Cancer by Regulating miR-770-5p/PARP1 Axis.
Cancer management and research
Zhu M, Yang L, Wang X.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2020
Cancer Research
No items found.
Key Finding
Knockdown of NEAT1 inhibited cisplatin resistance in ovarian cancer cells by up-regulating miR-770-5p and down-regulating PARP1, providing a new target for improving the efficacy of cisplatin-based therapy in ovarian cancer.
Countstar Connection
Countstar (model not specified) was the instrument used to assess flow-cytometry cell measurements in the study's cell samples during preparation for downstream cell analysis.
